ISSN: 1060-0280

Journal Home

Journal Guideline

Annals of Pharmacotherapy Q2 Unclaimed

SAGE Publications Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Annals of Pharmacotherapy is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology (medical) with an H index of 122. It has an SJR impact factor of 0,779 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,779.

Annals of Pharmacotherapy focuses its scope in these topics and keywords: drug, care, health, oral, treatment, administration, patient, thrombocytopenia, interaction, patients, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Pharmacology (medical) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,779

SJR Impact factor

122

H Index

238

Total Docs (Last Year)

521

Total Docs (3 years)

7071

Total Refs

1287

Total Cites (3 years)

409

Citable Docs (3 years)

2.25

Cites/Doc (2 years)

29.71

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Vancomycin-Induced Elevation of Liver Enzyme Levels

Cutaneous Ulceration Induced by Interferon Alfa

Book Review: Quick Reference to Cardiovascular Pharmacotherapy

Book Review: Encyclopedia of Clinical Pharmacy

Venous Thromboembolic Prophylaxis in Hospitalized Medical Patients

Authors' Reply

Cidofovir in the Treatment of Cytomegaloviral Disease

Studies Evaluating High-Dose Acyclovir, Intravenous Immune Globulin, and Cytomegalovirus Hyperimmunoglobulin for Prophylaxis against Cytomegalovirus in Kidney Transplant Recipients

Loss of Seizure Control Due to Anticonvulsant-Induced Hypocalcemia

Implications of SARS: Medical Geography and Surveillance in Disease Detection

Secondary Prevention of Coronary Heart Disease in the Elderly

SHOW MORE ARTICLES

Tenfold Medication Dose Prescribing Errors

ATOVAQUONE: A Review

Urinary Tract Infections During Pregnancy

Polymyxin B and Doxycycline Use in Patients with Multidrug-Resistant Acinetobacter baumannii Infections in the Intensive Care Unit

An Interventional Program to Improve Antibiotic Use

What is Optimal for Antibiotic Studies in Acute Otitis Media?

Direct Thrombin Inhibitors for Anticoagulation

Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir

Evaluation of the Impact of a tele-ICU Pharmacist on the Management of Sedation in Critically III Mechanically Ventilated Patients

Oral Ketoconazole in Cutaneous Fungal Infections

Validation of Four Clinical Indicators of Preventable Drug-Related Morbidity

Warfarin for Venous Thromboembolism Prophylaxis After Elective Hip or Knee Arthroplasty: Exploring the Evidence, Guidelines, and Challenges Remaining